Conference Day One

Wednesday 13th September 2023

7:30 am
Morning Registration & Networking

8:20 am Chairperson’s Opening Remarks

Unlocking the Secrets of the Skin Microbiome Through Sophisticated Research Tools, Sequencing & Data Analytics

8:30 am Powering Skin Microbiome Research Through Academia-Industry Partnerships

  • Se Jin Song CMI Director of Research Programs, UC San Diego Health Sciences


  • Revealing some of the industry-academic partnerships at UC San Diego
  • Exploring how such projects have progressed product development for products targeting the skin microbiome
  • Outlining future outlooks

9:00 am Partnering with CosmosID from Concept to Publication: a Case Study

  • Larry Weiss Chief Executive Officer & Founder, Symbiome


  • Exploring Symbiome's partnership for microbiome analysis 

9:15 am Developing a Therapeutic Vaccine for the Treatment of Acne Vulgaris


  • There is clear recognition of the need for new innovative approaches to treat acne vulgaris and improve the patient’s treatment journey and outcomes.
  • Sanofi is developing a therapeutic vaccine based on key antigens from the bacterium Cutibacterium acnes.
  • Pre-clinical data has been generated for the lead vaccine candidates, supporting transition into the clinical evaluation phase of the vaccine.

9:45 am
Speed Networking & Morning Break

Increasing Our Understanding of the Skin Microbiome to Enable Streamlined Product Development

10:45 am Redefining Our Understanding of What Makes a Healthy Skin Microbiome: Interindividual Differences & Healthy Aging


  • Uncovering the latest mechanistic understanding of healthy skin microbiome interactions
  • Understanding what contributes to a healthy microbiome
  • Exploring what encompasses ‘healthy aging’  

11:15 am SkinDuo™: An Effective Preservative Free Topical Serum & Food Supplement Combo, with Lactiplantibacillus plantarum for Acne Mitigation


  • Exploring how skin microbiome tailoring is a challenging but crucial aspect of research in immune-mediated inflammatory skin diseases like acne
  • Revealing how common preservatives used in functional ingredients can impact the skin microbiota, leading to a decrease in commensal bacteria survival
  • SkinDuoTM, a topical serum formulated with Lactiplantibacillus plantarum and natural enhancers, shows promising results in mitigating acne by improving lipid production and reducing anti-inflammatory markers in human ex vivo sebaceous gland models and also on human subjects

11:25 am Bacteriophage Endolysins for Microbiome Modulation


  • Exploring our latest research related to the use of Endolysins to modulate the microbiome 
  • Outlining how endolysins are being used in dermatology practices 
  • Uncovering future use case scenarios

11:55 am Enhancing your Microbiome Analysis to Meet Research, Product & Marketing Goals

  • Craig Tipton Director of Biostatistics, RTL Genomics & MicroGenDX
  • Caleb Phillips Chief Science Officer, RTL Genomics & MicroGenDX


  • A mechanism to navigate the complex metagenomic road connecting idea conception to final product
  • Collaborations that produce results
  • Leveraging research partnerships: case studies in microbiome consulting

12:25 pm
Lunch Break & Networking

Uncovering the Latest Advancements Across Cosmetic & Therapeutic Interventions for Skin Conditions

1:30 pm Using a Watercress Extract to Inhibit Bacterial Urease, Scavenge Ammonia & Soothe Skin as a Novel Treatment & Prevention in Incontinence Associated Dermatitis

  • Kyle Stewart Chief Executive Officer & Co-founder, Watercress Research Ltd.


  • Presentation of urease inhibiting data in-vitro on Proteus models
  • Demonstration of skin rejuvenating activity in a Labskin skin model. Antiinflammatory activity in a clinical trial of SLS-induced inflammation
  • Processing of watercress to yield a suitable extract for topical use

2:00 pm Bridging Industry & Consumer Needs: The Gut-Skin Axis


  • Exploring consumer needs, concerns and expectations when considering gut testing
  • Uncovering how industry can approach consumer needs in a practical way
  • Bridging the gap between gut and skin health concerns and solutions

2:30 pm Exploring Clinical Updates Across Acne Vulgaris Therapeutic Development

  • Hyun Kim Vice President & Head of Clinical Operations & Development, AOBiome


  • Highlighting current treatment options and challenges in acne vulgaris
  • Exploring the role of ammonia oxidizing bacteria in inflammation
  • Investigational B244 delivered as a topical spray for efficacy and safety in mild to moderate acne vulgaris

3:00 pm
Afternoon Break and Scientific Poster Session


Once the formal presentations are complete, let the learning and networking continue. The poster session allows you to connect with your peers in a relaxed atmosphere and continue to forge new and existing relationships. During this session scientific posters will be presented on the latest advancements in our understanding of the skin microbiome!

Exploring Novel Research & Product Development Considerations to Produce Higher Quality Microbiome-Based Products

4:00 pm Scalp Microbiome, the Nutrafol Experience


  • An introduction to scalp microbiome and its physiological relevance will be presented.
  • A novel formulation approach to clean and gentle formulations to rebalance the scalp will be introduce
  • In vitro and clinical data related to ingredients/product usage will be shared

4:30 pm Your Products & the Microbiome: Ingredients Matter

  • Nicole Scott Chief Executive Officer & Co-founder, Cybele Microbiome


  • Harnessing the optimal synergy of ingredients for microbiome targeting skincare
  • Maximizing the product lifespan through sophisticated ingredient choices
  • Outlining different ingredient options available

5:00 pm Roundtables: Interrogating the Microbial-Host Interplay

  • Julia Durack Vice President of Research & Product Development, Symbiome
  • Jay Tiesman Research Fellow, Procter & Gamble


  • Exploring our understanding of host-microbiome cross-talk
  • Outlining what technological innovations need to be adopted to improve our understanding
  • Uncovering biomarker development advances 

5:30 pm Chairperson’s Closing Remarks

5:40 pm
End of Conference Day One